An Umbrella Review of Clinical Efficacy and Adverse Cardiac Events Associated with Hydroxychloroquine or Chloroquine with or Without Azithromycin in Patients with COVID-19.

Shahsavarinia, Kavous; Ghojazadeh, Morteza; Ghabousian, Amir; Hatefnia, Faezeh; Soleimanpour, Maryam; Soleimanpour, Hassan

Shahsavarinia, Kavous; Ghojazadeh, Morteza; Ghabousian, Amir; Hatefnia, Faezeh; Soleimanpour, Maryam; Soleimanpour, Hassan.

Afiliación

Shahsavarinia K; Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Ghojazadeh M; Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Ghabousian A; Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hatefnia F; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Soleimanpour M; Social Determinants of Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Soleimanpour H; Emergency Medicine Research Team, Tabriz University of Medical Sciences, Tabriz, Iran.

Anesth Pain Med ; 11(4): e115827, 2021 Aug.

Article en En | MEDLINE | ID: mdl-34692436

Palabras clave

Azithromycin; COVID-19; Cardiac Events; Chloroquine; Hydroxychloroquine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies / Systematic_reviews Idioma: En Revista: Anesth Pain Med Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google